|
Yang, Yi; Rosenberg, Gary A (2011) Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 42:3323-8
|
|
Lo, Eng H; Rosenberg, Gary A (2009) The neurovascular unit in health and disease: introduction. Stroke 40:S2-3
|
|
Jian Liu, K; Rosenberg, Gary A (2005) Matrix metalloproteinases and free radicals in cerebral ischemia. Free Radic Biol Med 39:71-80
|
|
Wetzel, M; Tibbitts, J; Rosenberg, G A et al. (2004) Vulnerability of mouse cortical neurons to doxorubicin-induced apoptosis is strain-dependent and is correlated with mRNAs encoding Fas, Fas-Ligand, and metalloproteinases. Apoptosis 9:649-56
|
|
Adair, John C; Charlie, Julius; Dencoff, John E et al. (2004) Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease. Stroke 35:e159-62
|
|
Gursoy-Ozdemir, Yasemin; Qiu, Jianhua; Matsuoka, Norihiro et al. (2004) Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 113:1447-55
|
|
Pfefferkorn, Thomas; Rosenberg, Gary A (2003) Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion. Stroke 34:2025-30
|
|
Wetzel, M; Rosenberg, G A; Cunningham, L A (2003) Tissue inhibitor of metalloproteinases-3 and matrix metalloproteinase-3 regulate neuronal sensitivity to doxorubicin-induced apoptosis. Eur J Neurosci 18:1050-60
|
|
Mun-Bryce, Sheila; Lukes, Anton; Wallace, James et al. (2002) Stromelysin-1 and gelatinase A are upregulated before TNF-alpha in LPS-stimulated neuroinflammation. Brain Res 933:42-9
|
|
Rosenberg, Gary A (2002) Matrix metalloproteinases and neuroinflammation in multiple sclerosis. Neuroscientist 8:586-95
|
Showing the most recent 10 out of 37 publications
